"p16 as a biomarker to distinguish atypical ductal hyperplasia from duc" by Judy A. Tjoe, Brittany S. Last et al.
 

p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression

Affiliations

Advocate Aurora Health

Aurora Research Institute

Document Type

Abstract

Teammate Access

Link to Full Text

 

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 1
    • Policy Citations: 1
  • Usage
    • Abstract Views: 26
  • Captures
    • Readers: 109
see details

Share

COinS